• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Physicians Concerned About Private Equity's Impact on Health Care

Medically reviewed by Judith Stewart, BPharm. Last updated on March 23, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, March 22, 2024 -- Physicians express largely negative views about the impact of private equity (PE) on the health care system, according to a research letter published online March 11 in JAMA Internal Medicine.

Jane M. Zhu, M.D., from Oregon Health and Science University in Portland, and colleagues conducted a survey to assess physicians' views toward PE ownership. The analysis included 525 participants in an American College of Physicians research panel.

The researchers found that 9.9 percent of respondents reported that PE had expressed interest in purchasing their practice, while 5.5 percent worked for a PE-acquired health care entity. Most respondents (60.8 percent) viewed PE involvement in health care negatively, while 10.5 percent viewed it as positive or somewhat positive and 28.8 percent were neutral. Just over half of respondents (52.0 percent) viewed PE ownership as worse or much worse versus independent ownership, while 49.3 percent viewed PE ownership as worse or much worse versus not-for-profit hospital or health system ownership. PE was viewed unfavorably related to physician well-being (57.7 percent), health care prices or spending (57.0 percent), and health equity (51.2 percent), while health care innovation was noted as a potential positive. PE-employed physicians were less likely to report high professional satisfaction (extremely or somewhat satisfied) versus non-PE-employed physicians (44.8 versus 74.4 percent) and also reported lower autonomy (48.3 versus 66.3 percent).

"Our estimates of PE-involved physicians mirror those in the literature and suggest new areas for inquiry around clinical practice and workplace experience," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editor's Note (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.